(Q33606171)

28 July 2017

1 reference

title

Crystal-induced acute renal failure (English)

1 reference

28 July 2017

Perazella MA

1

1 reference

28 July 2017

language of work or name

English

0 references

publication date

1 April 1999

1 reference

American Journal of Medicine

28 July 2017

published in

1 reference

28 July 2017

volume

106

1 reference

28 July 2017

issue

4

1 reference

28 July 2017

page(s)

459-465

1 reference

Acute uric acid nephropathy

28 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900041-8

Acyclovir-induced renal failure. Clinical course and histology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900041-8

Renal function after acyclovir intravenous injection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900041-8

Acyclovir tolerance in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900041-8

Adverse effects of high-dose intravenous acyclovir in ambulatory patients with acute herpes zoster

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900041-8

Acute renal failure and coma secondary to acyclovir therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900041-8

Case report: acyclovir neurotoxicity and nephrotoxicity--the role for hemodialysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900041-8

Rapidly progressive acute renal failure due to acyclovir: case report and review of the literature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900041-8

Low-dose acyclovir and acute renal failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900041-8

Acute renal failure and coma after a high dose of oral acyclovir

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900041-8

Sulfadiazine crystalluria revisited. The treatment of Toxoplasma encephalitis in patients with acquired immunodeficiency syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900041-8

Sulfadiazine-associated obstructive nephropathy occurring in a patient with the acquired immunodeficiency syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900041-8

Renal US findings in sulfadiazine-induced crystalluria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900041-8

Sulphamethoxazole, hypoalbuminaemia, crystalluria, and renal failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900041-8

Acute renal failure due to sulphadiazine crystalluria in AIDS patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900041-8

Sulfadiazine-induced multiple urolithiasis and acute renal failure in a patient with AIDS and Toxoplasma encephalitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900041-8

Methotrexate-induced renal impairment: clinical studies and rescue from systemic toxicity with high-dose leucovorin and thymidine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900041-8

Effect of urine pH and flow on renal clearance of methotrexate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900041-8

Methotrexate and hemodialysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900041-8

Effective clearance of methotrexate using high-flux hemodialysis membranes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900041-8

Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900041-8

7 January 2021

Indinavir nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900041-8

Urinary stones in HIV-1-positive patients treated with indinavir

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900041-8

Crystalluria and urinary tract abnormalities associated with indinavir

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900041-8

Acute renal failure due to indinavir crystalluria and nephrolithiasis: report of two cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900041-8

Renal dysfunction in a human immunodeficiency virus-infected patient who was treated with indinavir

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900041-8

Triamterene and the kidney

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900041-8

Abnormal urinary sediment in patients on triamterene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900041-8

Triamterene nephrolithiasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900041-8

Triamterene-induced nephrolithiasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900041-8

Triamterene and renal stone formation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900041-8

Reversible acute renal failure from combined triamterene and indomethacin: a study in healthy subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900041-8

Anuric renal failure precipitated by indomethacin and triamterene.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900041-8

Effects of triamterene and amiloride on urinary sediment in hypertensive patients taking hydrochlorothiazide.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900041-8

Dyazide-induced reversible acute renal failure associated with intracellular crystal deposition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900041-8

Irreversible renal failure associated with triamterene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900041-8

Crystalluria: a neglected aspect of urinary sediment analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900041-8

Identification of crystals in kidneys of AIDS patients treated with foscarnet

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900041-8

Electrolyte and acid-base disorders associated with AIDS: an etiologic review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900041-8

Unusual complication of therapy with sulfamethoxazole-trimethoprim

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900041-8

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0002-9343(99)00041-8

1 reference

28 July 2017

1 reference